Leila Esazadeh, Rambod Khajeie, Alireza Hosseinikakhk,
Volume 14, Issue 6 (11-2020)
Abstract
Background and objectives: It has been suggested that concurrent training (CT) improves both health and performance during aging. However, possible effects of CT order have not been evaluated in menopausal women. Therefore, the aim of this study was to evaluate effects of CT order on follistatin, physical fitness factors and functional capacity of postmenopausal women.
Methods: In this semi-experimental study, 33 healthy, sedentary, postmenopausal women were divided into three groups of endurance training-resistance training (ET+RT; n=11), resistance training-endurance training (RT+ET; n=10) and control (C; n= 12). The training exercises were performed three times a week for eight weeks.
Results: Weight and body fat percentage did not differ significantly between the groups (P>0.05). Muscular strength, endurance and aerobic capacity increased significantly in both training groups (P<0.05). However, there was no significant difference between the effects of the training orders. There was a significant time × group interaction regarding the follistatin levels after the CT intervention. However, there was no significant difference in the follistatin levels between the groups.
Conclusion: Based on the results, the order of eight weeks of CT training does not significantly affect body fat percentage, physical fitness factors and functional capacity of postmenopausal women. However, the percentage changes in the mentioned variables are higher in the ET+RT exercise order.
Dr Adedeji Atere, Ms Elizabeth Ehuine, Dr Yekeen Kosamat, Dr Ilesanmi Ige,
Volume 19, Issue 3 (7-2025)
Abstract
Background: Menopause, characterized by the cessation of menstrual periods, often leads to bone diseases due to hormonal changes, particularly affecting calcium metabolism. This study aimed to evaluate bone-associated biomarkers and their correlation with parathyroid hormone (PTH) levels in postmenopausal women, shedding light on potential osteoporosis risks.
Methods: Sixty postmenopausal (PMP) women, along with 20 premenopausal (PRM) and 20 reproductive-age (RWA) women as controls, were included in this cross-sectional study. Blood samples were analyzed for PTH, vitamin D, uric acid, calcium, phosphorus, alkaline phosphatase (ALP), and estradiol levels.
Results: Statistical analysis revealed significantly higher levels of ALP and phosphorus, and lower levels of calcium, PTH, vitamin D, uric acid and estradiol in PMP and PRM groups compared to RWA (p<0.05). Moreover, PTH exhibited a significant negative correlation with ALP, and phosphorus, but a positive correlation with calcium, vitamin D, and estradiol in PMP women. ALP demonstrated a superior area under the ROC curve (AUROC) compared to other bone markers.
Conclusion: These findings highlight the reduced bone marker levels in postmenopausal women, potentially increasing the risk of bone loss and osteoporosis.